Serdar Dilbaz

Serdar Dilbaz

Auto-generated profile, based on publicly available information

Serdar Dilbaz

UNIVERSITY OF HEALTH SCIENCES, ANKARA ETLİK ZÜBEYDE HANIM HEALTH RESEARCH CENTER FOR GYNECOLOGICAL DISEASES

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

23 September 2022 in Journal of Turkish Society of Obstetric and Gynecology
Verified
Journal Article
Open access
BTBurcu Timur
Burcu Timur
OAOya Aldemir
Oya Aldemir
NINihat İnAn
Nihat İnAn
İKİskender Kaplanoğlu
İskender Kaplanoğlu
SDSerdar Dilbaz
Serdar Dilbaz
Ceramide (CER) is a bioactive component of the mitochondrial membrane. In this study, we will investigate the clinical importance of serum CER (sCER) and follicular fluid CER (ffCER) levels in the lipid synthesis pathway and their effect on poor oocyte quality and in vitro fertilization (IVF) outcome. This cross-sectional, case-control study was conducted in the IVF unit of a maternity hospital in the capital of Turkey, Ankara. A total of 88 women undergoing their first IVF cycle were included in this study patients were divided into 2 groups according to current diagnostic criteria for their ovarian reserves. Baseline sCER levels, and ffCER concentrations retrieved on the oocyte pickup day were measured. The mean age, body mass index, and infertility duration of the patients was similar between the groups (all p>0.05). There was also no significant difference in the clinical pregnancy rates (38.6% vs. 47.7%, p=0.127). sCER (15.6±6.5 vs. 23.5±8.9) and ffCER (82.5±34.3 vs. 116.4±46.5) levels were statistically significantly lower in the low ovarian reserve (LOR) group (both p<0.001). The performed receiver operating characteristic curve analysis revealed that sCER and ffCER levels could predict both LOR and pregnancy. This is the first study evaluating the sCER and ffCER levels of patients undergoing IVF treatment. CER may be used as an ovarian reserve markers and a biomarker capable of predicting IVF outcomes.

8 August 2019 in TURKISH JOURNAL OF MEDICAL SCIENCES
Verified
Journal Article
Open access
RÖRuna Özelçi
Runa Özelçi
OAOya Aldemi̇r
Oya Aldemi̇r
SDSerdar Di̇lBaz
Serdar Di̇lBaz
EOEnis Ozkaya
Enis Ozkaya
IKInci Kahyaoglu
Inci Kahyaoglu
ÖTÖzlem Moraloğlu Teki̇n
Özlem Moraloğlu Teki̇n
Diminished ovarian reserve (DOR) represents a major challenge in reproductive medicine, as it is often associated with poor ovarian stimulation response, high cycle cancellation rate, and low pregnancy rate. The aim of the present study is to compare the clinical pregnancy rates in intracytoplasmic sperm injection-embryo transfer (ICSI-ET) cycles in patients with different DOR etiologies. Patient data were recorded with a computer-based program called Success Estimation Using a Ranking Algorithm (SERA). Overall, 459 patients were divided into 3 groups according to their DOR etiologies (Group A: idiopathic, n = 81; Group B: age-related, n = 294; Group C: previous ovarian surgery, n = 84). Out of 459 stimulation cycles, 378 (82.4%) reached the oocyte retrieval stage, while 201 (43.8%) had embryo transfers. There was no significant difference between the patients with different DOR etiologies in terms of embryo transfer and cycle cancellation rate. The patients who had embryo transfer were 44 (52.4%) in Group A, 38 (46.9%) in Group B, and 119 (40.5%) in Group C. There were no significant differences between the three groups (P = 0.114). The percentages of women who had oocyte retrieval were 84.5% in Group A, 70% in Group B, and 80.3% in Group C (P = 0.104). While clinical pregnancy per transfer was 35.8% in Group A, 19.8% in Group B, and 29.5% in Group C, there was no statistically significant difference between the groups (P = 0.113) Although ovulation induction and ICSI-ET outcomes, including clinical pregnancy and live birth rates, were not significantly different with regards to the etiology of DOR, young women with DOR may benefit from assisted reproductive techniques.

1 November 2015 in Journal of Minimally Invasive Gynecology
Verified
Journal Article
Closed access
PDF file
BDB Dilbaz
B Dilbaz
FAF Akpinar
F Akpinar
SAS Altinbas
S Altinbas
SYS Yilmaz
S Yilmaz
RÖRuna Özelçi
Runa Özelçi
SDS Dilbaz
S Dilbaz

7 March 2024 in Journal of the Turkish-German Gynecological Association
Verified
Journal Article
Open access
CBCan Benlioğlu
Can Benlioğlu
YAYunus Aydın
Yunus Aydın
MBMustafa Bahçeci
Mustafa Bahçeci
VBVolkan Baltacı
Volkan Baltacı
SKSibel Bulgurcuoglu Kuran
Sibel Bulgurcuoglu Kuran
BABarış Ata
Barış Ata
The aim of this study was to describe characteristics and outcomes of assisted reproductive technology (ART) cycles performed in 2019 in Turkey. One-hundred and sixty-five ART centers in Turkey were invited to submit data. The survey was sent to center directors via e-mail with anonymous links by Qualtrics™. The survey involved questions about their patient characteristics, clinical practices, and outcomes. Forty-one (24.8%) centers responded to e-mails, and data gathered from 25 centers was included in the analyses. In 25 centers, 18,127 fresh or frozen transfers were carried out during the study period, of which 7796 (43.0%) were fresh and the rest were either frozen (45.2%) or embryo transfers (ET) with preimplantation genetic testing (PGT) (11.8%). The live birth rate per ET was as 30.6%, 40.1%, and 50.7% in fresh, frozen and PGT cycles, respectively. A single embryo was transferred in 65.3% of all transfers and singleton live births comprised 86.1% of all deliveries. For cycles with intrauterine insemination, 1407 were started in 2019, and 195 clinical pregnancies, 150 live births with 19 multiple pregnancies occurred. A total of 1513 ART cycles were initiated for foreign patients. Russia (29.6%), Germany (7.4%), Iraq (4.6%), Uzbekistan (3.1%), and Syria (1.4%) were the top five countries with most patients coming to Turkey for ART. The survey results are in parallel with the reports of international institutions and organizations. With repeated editions, the data collected with annual surveys can be used to inform ART practices in the coming years.

11 January 2024 in Reproductive Sciences
Verified
Journal Article
Closed access
PDF file
RÖRuna Özelçi
Runa Özelçi
NYNefise Nazlı Yenigül
Nefise Nazlı Yenigül
SDSerdar Dilbaz
Serdar Dilbaz
BDBerna Dilbaz
Berna Dilbaz
OAOya Aldemir
Oya Aldemir
ÖTÖzlem Moraloğlu Tekin
Özlem Moraloğlu Tekin